ASCLETIS PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 HKD | +0.79% |
|
-5.19% | -12.33% |
| Apr. 03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
| Apr. 03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |
Quotes 5-day view
Delayed Quote Hong Kong S.E.| 2024-04-16 | 2024-04-17 | 2024-04-18 | Today | 2024-04-19 | |
|---|---|---|---|---|---|
| Last | 1.28 $ | 1.3 $ | 1.27 $ | 1.28 $ | 1.28 $ |
| Volume | 528 000 | 98 000 | 1 037 000 | 950 000 | 950 000 |
| Change | 0.00% | +1.56% | -2.31% | +0.79% | +0.79% |
| Opening | 1.28 | 1.31 | 1.28 | 1.25 | 1.25 |
| High | 1.32 | 1.32 | 1.30 | 1.29 | 1.29 |
| Low | 1.27 | 1.29 | 1.26 | 1.21 | 1.21 |
Performance
| 1 day | +0.79% | ||
| Current month | -10.49% | ||
| 1 month | -20.00% | ||
| 3 months | -15.79% | ||
| 6 months | -24.71% | ||
| Current year | -12.33% | ||
| 1 year | -53.11% | ||
| 3 years | -55.71% | ||
| 5 years | -80.81% |
Volumes
marketsDaily volume
950 000
Estimated daily volume
950 000
Avg. Volume 20 sessions
540 879
Daily volume ratio
1.76
Avg. Volume 20 sessions HKD
692 325.12
Avg. Volume 20 sessions USD
88 407.84
Record volume 1
126 171 000
Record volume 2
82 741 320
Record volume 3
78 107 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (HKD)
1 189 139 589
Capitalization (USD)
164 243 960
Net sales (CNY)
56 596 000
Net sales (USD)
7 817 040
Number of employees
219
Sales / Employee (CNY)
258 429
Sales / Employee (USD)
35 694
Free-Float
28.28 %
Free-Float capitalization (HKD)
336 257 397
Free-Float capitalization (USD)
46 443 872
Average Daily Capital Traded
0.06%
Highs and lows
1 week
1.21
1.32
1 month
1.211.65
Current year
1.211.93
1 year
1.212.87
3 years
1.217.26
5 years
1.217.26
10 years
1.2114.90
Indicators
Moving average 5 days
1.28
Moving average 20 days
1.41
Moving average 50 days
1.60
Moving average 100 days
1.61
Price spread / (MMA5)
+0.16%
Price spread / (MMA20)
+10.12%
Price spread / (MMA50)
+24.73%
Price spread / (MMA100)
+25.84%
STIM
RSI 9 days
27.36
RSI 14 days
30.34
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.79% | 0.00% | -12.33% | -53.11% | 164M | ||
| -0.70% | -4.33% | -5.99% | -10.08% | 84.46B | ||
| +1.80% | -0.63% | +3.95% | -0.38% | 40.85B | ||
| -0.85% | -6.46% | -26.37% | -35.16% | 27.69B | ||
| -0.96% | -1.49% | +50.63% | +37.91% | 24.28B | ||
| -0.44% | -1.52% | -6.59% | -8.47% | 17.09B | ||
| -1.85% | -1.69% | -32.37% | -24.67% | 13.67B | ||
| -4.15% | -9.28% | -10.45% | -20.71% | 11.79B | ||
| +0.19% | -3.82% | -15.88% | -28.43% | 11.86B | ||
| -1.35% | +1.03% | -4.34% | -4.91% | 8.07B | ||
| -6.12% | +5.93% | +0.53% | +15.40% | 7.51B | ||
| -1.48% | -11.11% | -22.34% | -18.33% | 6.98B | ||
| -1.02% | +9.10% | -8.99% | +2.74% | 6.41B | ||
| +2.34% | +2.64% | -12.62% | +6.72% | 6.42B | ||
| +9.58% | +1.56% | +78.88% | +248.22% | 6.78B | ||
| -1.08% | -14.75% | -20.63% | -42.17% | 5.73B | ||
| Average | -0.33% | -2.71% | -2.81% | +4.03% | ||
| Weighted average by Cap. | -0.40% | -2.42% | -2.23% | -1.94% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
cde7f1b1acbab4d1c9a8e.tBVgiLshgIVscOuygxhkAcx2QpYN12ULluUFB7a18y8.5l4usdEZ37JfQLHQtXMqT7YzdfVfrxRy5IA1U_LmuXyBWzf530TM7yk5og
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:08:35 am | 1.28 | 1,000 | 950,000 |
| 03:59:20 am | 1.28 | 1,000 | 949,000 |
| 03:58:24 am | 1.28 | 1,000 | 948,000 |
| 03:57:10 am | 1.28 | 1,000 | 947,000 |
| 03:51:26 am | 1.28 | 1,000 | 946,000 |
| 03:41:22 am | 1.27 | 6,000 | 945,000 |
| 03:41:22 am | 1.27 | 1,000 | 939,000 |
| 03:34:17 am | 1.28 | 1,000 | 938,000 |
| 03:22:33 am | 1.28 | 2,000 | 937,000 |
| 03:11:11 am | 1.28 | 1,000 | 935,000 |
Monthly variations
Annual change
| 2024 | -13.01% | ||
| 2023 | -69.20% | ||
| 2022 | +44.07% | ||
| 2021 | +14.63% | ||
| 2020 | -3.37% | ||
| 2019 | -53.38% | ||
| 2018 | -54.50% |
- Stock Market
- Equities
- 1672 Stock
- Quotes Ascletis Pharma Inc.
